ATE278679T1 - Zwischenprodukte in der synthese von epothilonen und verfahren zu deren herstellung - Google Patents
Zwischenprodukte in der synthese von epothilonen und verfahren zu deren herstellungInfo
- Publication number
- ATE278679T1 ATE278679T1 AT99952092T AT99952092T ATE278679T1 AT E278679 T1 ATE278679 T1 AT E278679T1 AT 99952092 T AT99952092 T AT 99952092T AT 99952092 T AT99952092 T AT 99952092T AT E278679 T1 ATE278679 T1 AT E278679T1
- Authority
- AT
- Austria
- Prior art keywords
- synthesis
- epothilones
- production
- intermediate products
- desoxyepothione
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title abstract 3
- 238000003786 synthesis reaction Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 229930013356 epothilone Natural products 0.000 title 1
- HESCAJZNRMSMJG-KKQRBIROSA-N epothilone A Chemical compound C/C([C@@H]1C[C@@H]2O[C@@H]2CCC[C@@H]([C@@H]([C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1)O)C)=C\C1=CSC(C)=N1 HESCAJZNRMSMJG-KKQRBIROSA-N 0.000 title 1
- 239000013067 intermediate product Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- QXRSDHAAWVKZLJ-OXZHEXMSSA-N Epothilone B Natural products O=C1[C@H](C)[C@H](O)[C@@H](C)CCC[C@@]2(C)O[C@H]2C[C@@H](/C(=C\c2nc(C)sc2)/C)OC(=O)C[C@H](O)C1(C)C QXRSDHAAWVKZLJ-OXZHEXMSSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- HESCAJZNRMSMJG-HGYUPSKWSA-N epothilone A Natural products O=C1[C@H](C)[C@H](O)[C@H](C)CCC[C@H]2O[C@H]2C[C@@H](/C(=C\c2nc(C)sc2)/C)OC(=O)C[C@H](O)C1(C)C HESCAJZNRMSMJG-HGYUPSKWSA-N 0.000 abstract 1
- QXRSDHAAWVKZLJ-PVYNADRNSA-N epothilone B Chemical compound C/C([C@@H]1C[C@@H]2O[C@]2(C)CCC[C@@H]([C@@H]([C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1)O)C)=C\C1=CSC(C)=N1 QXRSDHAAWVKZLJ-PVYNADRNSA-N 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/26—Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9810659.4A GB9810659D0 (en) | 1998-05-18 | 1998-05-18 | Organic compounds |
PCT/EP1999/003354 WO1999059985A1 (en) | 1998-05-18 | 1999-05-14 | Intermediates for the synthesis of epothilones and methods for their preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE278679T1 true ATE278679T1 (de) | 2004-10-15 |
Family
ID=10832262
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99952092T ATE278679T1 (de) | 1998-05-18 | 1999-05-14 | Zwischenprodukte in der synthese von epothilonen und verfahren zu deren herstellung |
Country Status (9)
Country | Link |
---|---|
US (1) | US6350878B1 (de) |
EP (1) | EP1080082B1 (de) |
AT (1) | ATE278679T1 (de) |
AU (1) | AU4262299A (de) |
DE (1) | DE69920906T2 (de) |
ES (1) | ES2230895T3 (de) |
GB (1) | GB9810659D0 (de) |
PT (1) | PT1080082E (de) |
WO (1) | WO1999059985A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4579351B2 (ja) | 1996-12-03 | 2010-11-10 | スローン−ケッタリング インスティトュート フォア キャンサー リサーチ | エポチロンの合成とその中間体及びその類似物並びにその使用 |
US6867305B2 (en) | 1996-12-03 | 2005-03-15 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
US20050043376A1 (en) * | 1996-12-03 | 2005-02-24 | Danishefsky Samuel J. | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
US6204388B1 (en) | 1996-12-03 | 2001-03-20 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
FR2775187B1 (fr) | 1998-02-25 | 2003-02-21 | Novartis Ag | Utilisation de l'epothilone b pour la fabrication d'une preparation pharmaceutique antiproliferative et d'une composition comprenant l'epothilone b comme agent antiproliferatif in vivo |
US20020058286A1 (en) * | 1999-02-24 | 2002-05-16 | Danishefsky Samuel J. | Synthesis of epothilones, intermediates thereto and analogues thereof |
US6989450B2 (en) | 2000-10-13 | 2006-01-24 | The University Of Mississippi | Synthesis of epothilones and related analogs |
DE10164592A1 (de) * | 2001-12-21 | 2003-07-03 | Schering Ag | C1-C6-Epothilon-Fragmente und Verfahren für die Herstellung von C1-C6-Fragmenten von Epothilonen und deren Derivaten |
US6921769B2 (en) | 2002-08-23 | 2005-07-26 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
US7649006B2 (en) | 2002-08-23 | 2010-01-19 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
EP1767535B1 (de) | 2002-08-23 | 2009-12-02 | Sloan-Kettering Institute For Cancer Research | Synthese von Epothilonen, Zwischenprodukte davon, Analoga und ihre Verwendung |
GB0221312D0 (en) * | 2002-09-13 | 2002-10-23 | Novartis Ag | Organic compounds |
EP1589011A1 (de) | 2004-04-22 | 2005-10-26 | Schering Aktiengesellschaft | Neue chirale Heptin Derivate zur Herstellung von Epothilonen und Verfahren zu deren Herstellung |
CN103037903A (zh) | 2010-05-18 | 2013-04-10 | 天蓝制药公司 | 用于治疗自身免疫性疾病或其它疾病的组合物和方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE59609305D1 (de) * | 1995-11-17 | 2002-07-11 | Biotechnolog Forschung Gmbh | Epothilon-Derivate und deren Herstellung |
US5969145A (en) | 1996-08-30 | 1999-10-19 | Novartis Ag | Process for the production of epothilones and intermediate products within the process |
EP0923583A1 (de) * | 1996-08-30 | 1999-06-23 | Novartis AG | Verfahren zur herstellung von epothilonen und zwischenprodukte innerhalb des verfahrens |
JP4579351B2 (ja) * | 1996-12-03 | 2010-11-10 | スローン−ケッタリング インスティトュート フォア キャンサー リサーチ | エポチロンの合成とその中間体及びその類似物並びにその使用 |
US6441186B1 (en) | 1996-12-13 | 2002-08-27 | The Scripps Research Institute | Epothilone analogs |
US6399638B1 (en) | 1998-04-21 | 2002-06-04 | Bristol-Myers Squibb Company | 12,13-modified epothilone derivatives |
US6498257B1 (en) | 1998-04-21 | 2002-12-24 | Bristol-Myers Squibb Company | 2,3-olefinic epothilone derivatives |
DE19820599A1 (de) | 1998-05-08 | 1999-11-11 | Biotechnolog Forschung Gmbh | Epothilonderivate, Verfahren zu deren Herstellung und deren Verwendung |
DE19826988A1 (de) | 1998-06-18 | 1999-12-23 | Biotechnolog Forschung Gmbh | Epothilon-Nebenkomponenten |
AU5036999A (en) | 1998-06-30 | 2000-01-17 | Schering Aktiengesellschaft | Epothilon derivatives, their preparation process, intermediate products and their pharmaceutical use |
CN1205208C (zh) * | 1999-02-22 | 2005-06-08 | 生物技术研究股份有限公司 | C-21修饰的环氧噻酮类化合物 |
US6211412B1 (en) * | 1999-03-29 | 2001-04-03 | The University Of Kansas | Synthesis of epothilones |
-
1998
- 1998-05-18 GB GBGB9810659.4A patent/GB9810659D0/en not_active Ceased
-
1999
- 1999-05-14 PT PT99952092T patent/PT1080082E/pt unknown
- 1999-05-14 ES ES99952092T patent/ES2230895T3/es not_active Expired - Lifetime
- 1999-05-14 AU AU42622/99A patent/AU4262299A/en not_active Abandoned
- 1999-05-14 EP EP99952092A patent/EP1080082B1/de not_active Expired - Lifetime
- 1999-05-14 AT AT99952092T patent/ATE278679T1/de active
- 1999-05-14 DE DE69920906T patent/DE69920906T2/de not_active Expired - Lifetime
- 1999-05-14 WO PCT/EP1999/003354 patent/WO1999059985A1/en active IP Right Grant
-
2000
- 2000-11-17 US US09/715,674 patent/US6350878B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
GB9810659D0 (en) | 1998-07-15 |
ES2230895T3 (es) | 2005-05-01 |
WO1999059985A1 (en) | 1999-11-25 |
DE69920906D1 (de) | 2004-11-11 |
US6350878B1 (en) | 2002-02-26 |
DE69920906T2 (de) | 2006-03-09 |
PT1080082E (pt) | 2005-02-28 |
EP1080082B1 (de) | 2004-10-06 |
AU4262299A (en) | 1999-12-06 |
EP1080082A1 (de) | 2001-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE278679T1 (de) | Zwischenprodukte in der synthese von epothilonen und verfahren zu deren herstellung | |
NO940038D0 (no) | Arylsulfonamido-substituerte hydrokamsyrer | |
ATE184194T1 (de) | Immunsuppressive und antiallergische verbindungen; z.b. n-(3-oxohexanoyl)- homoserinlacton | |
IS6257A (is) | Frumuviðloðunartálmar | |
NO307047B1 (no) | Nye hydroksyetylaminosulfonamider som er nyttige som retrovirale proteasehemmere, farmasøytisk preparat inneholdende slike, og anvendelse derav | |
DE69937045D1 (de) | Cyclische amidderivate | |
TR200001239T2 (tr) | Tiyazolidinediyon türevlerini hazırlama prosesi. | |
DK0595111T3 (da) | Carbazolonderivater og fremgangsmåde til deres fremstilling | |
ATE159728T1 (de) | Cis-epoxide derivate, verwendbar als irreversible hiv-protease inhibitoren und verfahren und zwischenprodukte zu ihrer herstellung | |
HRP20000467B1 (en) | Process for the preparation of simvastatin and derivatives thereof | |
DE60014936D1 (de) | Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel | |
ATE322470T1 (de) | Funktionalisierte höhere diamantoide | |
DE60000402D1 (de) | Prozess zur herstellung von zwischebprodukten für imidazodeazepinen | |
ATE189886T1 (de) | Synthese von carbonsäurederivaten | |
ATE423089T1 (de) | Verfahren zur herstellung von butantriol- derivaten | |
MX9803552A (es) | Metodos para producir aminofenilsulfonil carbamidas y productos intermediarios para usarse en el procedimiento. | |
NO20001541L (no) | Nye substituerte dimeriske forbindelser, fremgangsmÕte for deres fremstilling og farmasøytiske sammensetninger inneholdende dem | |
CA2284646A1 (en) | Synthesis of intermediates useful in preparing tricyclic compounds | |
ATE508109T1 (de) | Verfahren zur herstellung von optisch aktiven sulfonamiden und zwischenprodukte zur deren synthese | |
WO2001021585A3 (de) | Bis-(aziridino-1-hydroxyiminomethyl)-derivate, verfahren zu deren herstellung und deren verwendung als antitumormittel | |
ATE399779T1 (de) | Zwischenprodukte für die herstellung von neuraminidase-inhibitor-konjugaten | |
YU37902A (sh) | Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3- benzazocini i njihova primena kao lekova | |
ATE340157T1 (de) | Zwischenprodukte, verfahren für deren herstellung und deren gebrauch | |
ATE244217T1 (de) | Herstellung von beta-mehtylcarbapenem- zwischenprodukten | |
DE69916287D1 (de) | Verfahren zur synthese von carbapenem-zwischenprodukten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1080082 Country of ref document: EP |